United States· US:0024-5862_fec4102e-2c66-433f-ab6c-7f420b4c3a86
Mozobil
A plerixafor product containing plerixafor, registered in United States by Sanofi-Aventis U.S. LLC. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Plerixafor is registered in 17 of 19 countries.
Countries holding a registration under ATC L03AX16 (plerixafor), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Plerixafor · ATC L03AX16
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PLERIXAFOR
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Country
- United States (US)
- ATC code
- L03AX16
- ATC class
- Plerixafor
- Defined daily dose
- 16.8 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110024-5862-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Plerixafor in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceMOZOBIL 20 mg/ml, solution pour injectionSANOFI (PAYS-BAS)
- NetherlandsMozobil 20 mg/ml, oplossing voor injectieGenzyme Europe BV
- IrelandMozobil 20 mg/ml Solution for injectionGenzyme Europe B.V.
- GermanyPlerixafor AmaroxAmarox Pharma Gmbh
- SpainMOZOBIL 20 mg/ml SOLUCION INYECTABLESanofi B.V.
- United KingdomMozobil 24mg/1.2ml solution for injection vialsSanofi
- FinlandMozobilOrifarm Oy
- SwedenMozobil 20 mg/ml Injektionsvätska, lösningSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Plerixafor Stada, Plerixafor Teva
- Bulgaria · Plerixafor Msn
- Czechia · Pleforbil, Plerixafor Msn
- Germany · Plerixafor Amarox, Plerixafor Puren
- Denmark · Plerixafor Seacross, Plerixafor Teva
- Estonia · Plerixafor Auxilia
- Spain · Plerixafor Eugia, Plerixafor Glenmark
- Finland · Plerixafor Seacross, Plerixafor Viatris
- France · Plerixafor Arrow, Plérixafor Eg
- United Kingdom (Northern Ireland) · Plerixafor Amarox Limited, Plerixafor Eugia (Uk)
- Croatia · Pleriksafor Msn, Pleriksafor Onkogen
- Hungary · Plerixafor Msn, Plerixafor Onkogen
- Ireland · Plerixafor Msn Labs Europe, Plerixafor Seacross
- Iceland · Mozobil, Plerixafor Accord
- Italy · Plerixafor Aurobindo, Plerixafor Eg
- Liechtenstein · Mozobil, Plerixafor Accord
- Lithuania · Plerixafor Auxilia
- Netherlands · Plerixafor Amarox, Plerixafor Sandoz
- Norway · Mozobil, Plerixafor Accord
- Poland · Plerixafor Biofar, Plerixafor Msn
- Portugal · Plerixafor Eugia, Plerixafor Mylan
- Romania · Plerixafor Msn Labs Europe
- Sweden · Plerixafor Seacross, Plerixafor Teva
- Slovenia · Pleriksafor Onkogen, Pleriksafor Teva
- Slovakia · Plerixafor Msn, Plerixafor Onkogen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a75fc125-2df2-4d76-bb46-cf3a31ff2dc2 GET /v1/drugs/a75fc125-2df2-4d76-bb46-cf3a31ff2dc2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "SUBCUTANEOUS",
"source": "ndc",
"strength": "24",
"substance": "PLERIXAFOR",
"productndc": "0024-5862",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1.2mL",
"application_number": "NDA022311",
"marketing_category": "NDA"
}See everything about plerixafor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.